Body Good Studio
GLP1 EDUCATION

Monjaro Weight Loss: How It Works, Results & What to Expect

Dr. Linda Moleon, MDMay 18, 2026

What Is Monjaro and Why Is Everyone Talking About It?

If you've been researching medical weight loss options, you've probably come across the name Monjaro — or heard it mentioned in weight loss communities, TikTok threads, or even by your doctor. Monjaro weight loss has become one of the most searched terms in health and wellness, and for good reason: the medication delivers clinically significant results for adults struggling with weight management.

Monjaro is the brand name for tirzepatide, a once-weekly injection initially approved by the FDA in 2022 for type 2 diabetes management under the brand name Mounjaro. In November 2023, the same medication was approved specifically for chronic weight management under a different brand name — Zepbound. Whether you see it spelled "Monjaro," "Mounjaro," or "Monjiro," people are often referring to the same active ingredient: tirzepatide.

This article will walk you through how Monjaro works for weight loss, what the clinical data actually shows, what side effects to expect, and how you can access it through clinician-supervised telehealth programs.

How Monjaro Works for Weight Loss

Monjaro is a dual GIP/GLP-1 receptor agonist. That means it mimics two naturally occurring hormones in your body:

  • GLP-1 (glucagon-like peptide-1): Slows gastric emptying, reduces appetite, and helps regulate blood sugar.

  • GIP (glucose-dependent insulinotropic polypeptide): Enhances insulin secretion and may influence how your body stores fat.
  • By activating both pathways, Monjaro influences hunger signals, food intake, and metabolic function in ways that single-agent GLP-1 medications like semaglutide do not. This dual mechanism is one reason tirzepatide has shown stronger average weight loss results in head-to-head clinical trials.

    When you take Monjaro, you're likely to notice:

  • • Reduced appetite and fewer cravings

  • • Feeling full sooner and staying satisfied longer

  • • Less preoccupation with food between meals

  • • Gradual, sustained weight loss over months
  • It's not a stimulant. It doesn't artificially speed up your metabolism. Instead, it works with your body's existing hormone systems to restore more normal signaling around hunger and satiety — signaling that often becomes dysregulated in people with obesity or insulin resistance.

    What the Clinical Trials Show: SURMOUNT Results

    The FDA's approval of tirzepatide for weight loss was based primarily on the SURMOUNT clinical trial program, which enrolled thousands of adults with obesity or overweight with at least one weight-related health condition.

    Here's what the data revealed:

  • • In the SURMOUNT-1 trial, participants taking the highest dose of tirzepatide (15 mg weekly) lost an average of 20.9% of their body weight over 72 weeks.

  • • Those on the 10 mg dose lost an average of 19.5% of their body weight.

  • • The 5 mg dose resulted in an average loss of 15% of body weight.

  • • Participants in the placebo group lost about 3.1% of their body weight.
  • These are averages — some people lost more, some less. But the consistency and magnitude of weight loss across the tirzepatide groups were striking, especially compared to older weight loss medications.

    Importantly, participants also saw improvements in:

  • • Waist circumference

  • • Blood pressure

  • • Triglycerides and cholesterol markers

  • • Hemoglobin A1c (a marker of blood sugar control)
  • These secondary benefits matter. Weight loss isn't just about appearance — it's about reducing the metabolic and cardiovascular risks that come with excess weight.

    If you're exploring compounded tirzepatide through a telehealth platform, you're accessing the same active ingredient studied in these trials, formulated by licensed compounding pharmacies and prescribed by licensed clinicians.

    What Realistic Weight Loss Looks Like on Monjaro

    Clinical trial averages are helpful, but real-world results vary. Here's what you can reasonably expect:

    Timeline

  • Weeks 1–4: Appetite suppression begins. You may lose 2–5 pounds, mostly from reduced calorie intake and water weight.

  • Months 2–3: Weight loss accelerates as your dose is titrated upward. Expect 1–2 pounds per week on average.

  • Months 4–6: Continued gradual loss. Plateaus are normal and don't mean the medication stopped working.

  • Months 6–12: Most people reach their maximum benefit by month 9–12, losing 15–25% of their starting weight if adherent.
  • Factors That Influence Results

    Monjaro is powerful, but it's not magic. Your results depend on:

  • Adherence: Taking your injection consistently, every week, at the right dose.

  • Diet quality: You still need to eat. Monjaro reduces hunger, but choosing nutrient-dense foods supports energy, muscle mass, and long-term success.

  • Physical activity: Movement isn't required for weight loss on Monjaro, but it helps preserve lean mass and improves metabolic health.

  • Sleep and stress: Poor sleep and chronic stress can blunt weight loss through hormonal pathways Monjaro doesn't directly address.

  • Starting weight and metabolic health: People with higher baseline weight or insulin resistance may see faster initial drops.
  • If you're not sure where to start, Body Good Studio offers nutrition coaching and clinician support as part of its medical weight loss programs — so you're not navigating this alone.

    Common Side Effects and How to Manage Them

    Like all GLP-1 and GIP agonists, Monjaro comes with a predictable set of gastrointestinal side effects, especially during dose escalation.

    Most Common Side Effects

  • • Nausea

  • • Diarrhea

  • • Constipation

  • • Decreased appetite (this is also the therapeutic effect)

  • • Fatigue

  • • Abdominal discomfort or bloating
  • These symptoms are usually mild to moderate and improve as your body adjusts. Starting at a low dose and increasing slowly — as your clinician prescribes — minimizes the intensity.

    Practical Management Tips

  • Eat smaller, more frequent meals. Large portions can trigger nausea.

  • Avoid high-fat and greasy foods, which slow digestion further.

  • Stay hydrated. Sip water throughout the day; dehydration worsens nausea and constipation.

  • Take your injection at night so any nausea hits while you're asleep.

  • Ask about anti-nausea support. If nausea is interfering with your daily life, ondansetron anti-nausea medication can help you stay on protocol without dropping out.
  • Some people also report feeling more tired during the first few weeks. This can be partly due to the calorie deficit, and partly a side effect of the medication. A B12 injection can help combat energy dips, especially if you're eating less meat or fortified foods.

    Rare but Serious Risks

    While uncommon, be aware of:

  • Pancreatitis: Severe, persistent abdominal pain that radiates to the back. Stop the medication and seek care immediately.

  • Gallbladder issues: Rapid weight loss increases gallstone risk.

  • Thyroid tumors: Seen in animal studies; avoid if you have a personal or family history of medullary thyroid carcinoma or MEN2 syndrome.
  • Your prescribing clinician will screen for contraindications during your new patient consultation to ensure Monjaro is safe for you.

    Monjaro vs. Ozempic and Wegovy: What's the Difference?

    You've probably also heard of Ozempic and Wegovy — both brand names for semaglutide, a GLP-1 receptor agonist. Here's how they compare:

    | Feature | Monjaro (tirzepatide) | Ozempic/Wegovy (semaglutide) |
    |---------|------------------------|-------------------------------|
    | Mechanism | Dual GIP/GLP-1 agonist | GLP-1 agonist only |
    | Average weight loss | ~20% body weight | ~15% body weight |
    | Injection frequency | Once weekly | Once weekly |
    | FDA approval for weight loss | Yes (as Zepbound) | Yes (Wegovy only) |
    | Nausea profile | Similar or slightly less | Common |

    Both are effective. Monjaro tends to produce slightly more weight loss on average, but individual response varies. Some people tolerate one better than the other. If you've tried semaglutide and didn't get the results you wanted — or couldn't tolerate it — switching to tirzepatide is a reasonable next step.

    You can explore compounded semaglutide or tirzepatide options through Body Good Studio, depending on what your clinician recommends based on your history and goals.

    How to Access Monjaro for Weight Loss

    Monjaro (branded tirzepatide) is expensive — often $1,000+ per month without insurance. Zepbound, the weight-loss-specific brand, faces similar pricing and supply challenges. Many people are turning to compounded tirzepatide, which offers the same active ingredient at a fraction of the cost.

    Here's how the process works:

    1. Complete a medical intake. This can be done online through a telehealth platform. You'll answer questions about your weight history, health conditions, medications, and goals.
    2. Consult with a licensed clinician. A physician, nurse practitioner, or physician assistant reviews your information and determines if you're a candidate.
    3. Receive a prescription. If approved, your prescription is sent to a licensed compounding pharmacy.
    4. Medication is shipped to your door. Discreet packaging, temperature-controlled shipping, with needles and alcohol swabs included.
    5. Ongoing support. Dosing adjustments, side effect management, and nutrition guidance as needed.

    Body Good Studio's platform is designed to make this simple. You can check your eligibility and insurance coverage probability using our free insurance probability checker, and most members receive a treatment plan within 24 hours of their consultation.

    If you want to try tirzepatide without a long-term commitment, the tirzepatide one-time trial lets you test the medication for a single month before deciding whether to continue.

    Is Monjaro Right for You?

    Monjaro is FDA-approved for adults with:

  • • A BMI of 30 or higher (obesity), OR

  • • A BMI of 27 or higher (overweight) with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.
  • It is not approved for cosmetic weight loss in people at a healthy weight. It's also not recommended if you:

  • • Are pregnant, breastfeeding, or planning to become pregnant soon

  • • Have a personal or family history of medullary thyroid carcinoma

  • • Have a history of pancreatitis

  • • Have severe gastroparesis or gastrointestinal disorders
  • Your clinician will assess your full medical history before prescribing. If GLP-1 or GIP agonists aren't right for you, there are other evidence-based options — including bupropion / naltrexone, a non-GLP-1 combination that works through different pathways.

    Frequently Asked Questions

    How long do I need to stay on Monjaro?

    Monjaro is intended for long-term use. Most people regain weight if they stop the medication, because the underlying hormonal and metabolic factors that contributed to weight gain are still present. Think of it like managing blood pressure or cholesterol — it's a chronic condition that benefits from ongoing treatment.

    Can I use Monjaro if I don't have diabetes?

    Yes. Tirzepatide is FDA-approved for weight management in adults without diabetes, as long as you meet the BMI criteria. You don't need to have type 2 diabetes to qualify.

    Will insurance cover Monjaro for weight loss?

    Some insurers cover Zepbound (the weight-loss-branded tirzepatide), but many do not. Compounded tirzepatide is generally not covered by insurance, but it's significantly more affordable out-of-pocket. Body Good Studio works with patients to find the most cost-effective route, and offers transparent pricing with no surprise fees.

    What happens if I miss a dose?

    If you miss a dose and it's within 4 days of your scheduled injection, take it as soon as you remember. If more than 4 days have passed, skip that dose and resume your normal schedule. Don't double up.

    Can I drink alcohol on Monjaro?

    Moderate alcohol is generally safe, but many people find they have less interest in drinking while on the medication. Alcohol can also worsen nausea and may increase the risk of low blood sugar if you're also taking other diabetes medications.

    Ready to Start Your Weight Loss Journey?

    Monjaro weight loss is not hype — it's evidence-based medicine backed by robust clinical trials and real-world success. If you've been struggling with weight despite your best efforts, tirzepatide may be the tool that finally makes sustainable progress possible.

    Body Good Studio's clinician-prescribed programs make medical weight loss accessible, affordable, and personalized. Take our free 60-second quiz to see if you qualify — most members get a treatment plan in under 24 hours. Whether you're exploring GLP-1s for the first time or looking for a more supportive, transparent provider, we're here to help you move forward with confidence.

    Ready to get started?

    Take our quiz to find the perfect program for you.

    Take the Quiz